Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung cancer study sheds light on hidden sexual struggles

NCT ID NCT06018376

Knowledge-focused Sponsor: Fundación GECP Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at sexual problems in 553 adults with lung cancer. Researchers wanted to find out how common these issues are and how severe they can be. The goal is to help doctors better support patients during and after cancer treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

553 people

The number who actually took part.

Started

Jul 2023

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with lung cancer stages IB to IV with ECOG ≤ 2 between 18 and 70 years old that received systemic oncological treatment for at least 3 months.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age greater than or equal to 18 years and less than or equal to 70 years. * Diagnosis of lung cancer stages IB to IV. * Having received systemic oncological treatment for at least 3 months or being in oncological follow-up after having received systemic treatment for a minimum of 3 months with stable tumor disease or partial or complete response in images. * ECOG ≤ 2 Exclusion Criteria: * Patients with comorbidities (renal failure, cardiovascular diseases or similar) not controlled with corresponding medical management. * Individuals with physical disability or cognitive impairment that prevents them from completing the electronic data collection form.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm physiological sexual disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer Sexual dysfunction

Contacts and locations

Locations

  • ALIADAS Instituto Nacional de Enfermedades Neoplasicas

    Surquillo, Perú, 15038, Peru

  • Centro Hospitalar do Porto

    Porto, Porto District, 4099-001, Portugal

  • Clinica del Occidente

    Cali, Cali, Colombia

  • Clínica Universitaria Colombia

    Bogotá, Bogota D.C., Colombia

  • Clínica de Medellín

    Medellín, MEdellín, Colombia

  • Hematooncologos SA

    Cali, Cali, Colombia

  • Hospital Clínico San Carlos

    Madrid, Madrid, 28040, Spain

  • Hospital Clínico Universitario de Valladolid

    Valladolid, Valladolid, 47003, Spain

  • Hospital Clínico de Salamanca

    Salamanca, Salamanca, 37007, Spain

  • Hospital General Universitario de Ciudad Real

    Ciudad Real, Ciudad Real, 13005, Spain

  • Hospital General Universitario de Valencia

    Valencia, Valencia, 46014, Spain

  • Hospital General de Elche

    Elche, Alicante, 03203, Spain

  • Hospital General de Granollers

    Granollers, Barcelona, 08402, Spain

  • Hospital Infanta Sofia

    San Sebastián de los Reyes, Madrid, 28702, Spain

  • Hospital La Mancha Centro

    Alcázar de San Juan, Ciudad Real, 13600, Spain

  • Hospital Universitari Son Llatzer

    Palma de Mallorca, Palma de Mallorca, 07198, Spain

  • Hospital Universitari Vall d' Hebron

    Barcelona, Barcelona, 08035, Spain

  • Hospital Universitario Cruces

    Barakaldo, Vizcaya, 48903, Spain

  • Hospital Universitario Fundación Jiménez Díaz

    Madrid, Madrid, 28040, Spain

  • Hospital Universitario La Fe

    Valencia, Valencia, 46026, Spain

  • Hospital Universitario Lucus Augusti

    Lugo, Lugo, 27003, Spain

  • Hospital Universitario Nuestra Señora de Candelaria

    Santa Cruz de Tenerife, Santa Cruz de Tenerife, 38010, Spain

  • Hospital Universitario Puerta de Hierro

    Majadahonda, Madrid, 28222, Spain

  • Hospital de Fuenlabrada

    Fuenlabrada, Madrid, 28942, Spain

  • Hospitalario Universitario A Coruña

    A Coruña, La Coruña, 15006, Spain

  • ICO Badalona, Hospital Germans Trias i Pujol

    Badalona, Barcelona, 08916, Spain

  • Instituto Alexander Flemming

    Buenos Aires, Buenos Aires, Argentina

  • Oncomedica, IMAT

    Montería, Monteria, Colombia

  • Xarxa sanitaria Santa Tecla- Tarragona

    Tarragona, Tarragona, 43003, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.